Klöckner Pentaplast Announces $25m Investment in Capacity Expansion in North America

Klöckner Pentaplast’s Pharma & Medical Device Division announced it will add to its global production capacity in North America.

"Our significant expansion plans reflect our dedication to servicing customers’ needs now, and in the future" says Tracey Peacock, President kp PMD. "The additional coating and laminating capability suitable for the production of Pentapharm and Pentamed packaging films will service the North American pharmaceutical and medical device industry. We are excited to support the growing high barrier product segments by investing in best in class coating and laminating capabilities, enabling new performance levels in barrier protection."

kp PMD is investing $25 million over the next few years in technology and processes to ensure they deliver innovative, functional and safe products for customers. This investment in North America supplement earlier announcements by kp this year, highlighting their capacity expansions in Switzerland and Brazil. kp plans for the new capability in North America to be operational in 2020.

-----------------------------------------------------------------------------
Editor's Note:

To apply for becoming a contributor of En-CPhI.cn,

welcome to send your CV and sample works to us,

Email: Julia.Zhang@ubmsinoexpo.com.